jcp Videos

Videos

Videos

Reimagining Clinical Trials in the Community Setting

10/20/2023

Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.

Ivy Altomare, MD, Flatiron...

10/20/2023

Journal of Clinical Pathways

Videos

Multiple Ethnicities Study Explores A Connection Between Type 2 Diabetes and Urinary Bladder Cancer

10/12/2023

David Bogumil ;

David Bogumil, PhD, details his findings on a connection between type 2 diabetes and urinary bladder cancer for African American, European American, Japanese American, Latin American, and Native Hawaiian populations.

David Bogumil, PhD, details his...

10/12/2023

Journal of Clinical Pathways

Conference Coverage

The Future of AI in Cancer Care

10/08/2023

Will Shapiro ;

Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.

Will Shapiro, vice president of...

10/08/2023

Journal of Clinical Pathways

Conference Coverage

AI in Cancer Care: Separating Fact from Fiction

10/06/2023

James Hamrick , MD, MPH;

James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.

James Hamrick, MD, discusses his...

10/06/2023

Journal of Clinical Pathways

Conference Coverage

CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home

10/03/2023

Barbara McAneny , MD;

CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...

CPC & CBEx faculty member...

10/03/2023

Journal of Clinical Pathways

Videos

AI Technology in Oncology Care: Thoughts From The Oncology Institute

10/02/2023

Daniel Virnich , MD;

Yale Podnos , MD;

Nikhil Buduma ;

Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...

Daniel Virnich, MD, CEO of The...

10/02/2023

Journal of Clinical Pathways

Videos

How Cone Health Uses Clinical Pathways to Deliver Optimal Patient Care

09/28/2023

Andre Harvin , PharmD;

In this interview, Andre Harvin, PharmD, chief pharmacy officer and vice president of Pharmacy Services at Cone Health, breaks down how their cancer center develops and utilizes clinical pathways and discusses how their team stays up to date...

In this interview, Andre Harvin,...

09/28/2023

Journal of Clinical Pathways

Videos

Care Management Programs vs Value-Based Programs: The Path Forward

09/28/2023

Barry Russo , MBA;

Brandy Manning , MSN, RN, OCN;

Tanya Park ;

Amy Valley , PharmD;

In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...

In this Cancer Care Business...

09/28/2023

Cancer Care Business Exchange

Videos

St. Elizabeth’s Innovative Cancer Screening Outreach Model

09/22/2023

Michael Gieske , MD;

Jamie Ries , BSN, RN;

Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.

Michael Gieske, MD, and Jamie...

09/22/2023

Journal of Clinical Pathways

Videos

The Hunt for Value in Value-Based Care: How to Meet Stakeholders' Evolving Demands

09/18/2023

Frederick M. Schnell , MD, FACP;

Frederick Schnell, MD, FACP, Community Oncology Alliance, previews his session at CPC + CBEx in October on market dynamics that are affecting the implementation of value-based cancer care.

Frederick Schnell, MD, FACP,...

09/18/2023

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products